Joshua A Salomon

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi Empirically calibrated model of hepatitis C virus infection in the United States
    Joshua A Salomon
    Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    Am J Epidemiol 156:761-73. 2002
  2. ncbi Healthy life expectancy: comparison of OECD countries in 2001
    Colin D Mathers
    Global Program on Evidence for Health Policy, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Aust N Z J Public Health 27:5-11. 2003
  3. ncbi Global patterns of healthy life expectancy in the year 2002
    Colin D Mathers
    Evidence and Information for Policy, World Health Organization, Avenue Appia, Geneva, Switzerland
    BMC Public Health 4:66. 2004
  4. ncbi Global patterns of healthy life expectancy for older women
    Colin D Mathers
    Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    J Women Aging 14:99-117. 2002
  5. ncbi Global burden of disease 2005: call for collaborators
    Christopher J L Murray
    Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98104, USA
    Lancet 370:109-10. 2007
  6. ncbi Can we reverse the HIV/AIDS pandemic with an expanded response?
    John Stover
    Futures Group International, Glastonbury, CT, USA
    Lancet 360:73-7. 2002
  7. ncbi Prospects for advancing tuberculosis control efforts through novel therapies
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e273. 2006
  8. ncbi [Priority setting for health interventions in Mexico's System of Social Protection in Health]
    Eduardo Gonzalez-Pier
    Unidad de Análisis Económico, Secretaria de Salud, Mexico, Paseo de la Reforma 450, PH, Col Juárez, 06600 Mexico, DF, Mexico
    Salud Publica Mex 49:S37-52. 2007
  9. ncbi Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
    Sun Young Kim
    Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
    Bull World Health Organ 85:833-42. 2007
  10. ncbi Impact of HIV on novel therapies for tuberculosis control
    Maria S Sanchez
    Department of Environmental Science, Policy and Management, University of California, Berkeley, California 94720 3114, USA
    AIDS 22:963-72. 2008

Collaborators

Detail Information

Publications19

  1. ncbi Empirically calibrated model of hepatitis C virus infection in the United States
    Joshua A Salomon
    Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    Am J Epidemiol 156:761-73. 2002
    ..These findings have important implications both for individual clinical decisions and for broader public health policy...
  2. ncbi Healthy life expectancy: comparison of OECD countries in 2001
    Colin D Mathers
    Global Program on Evidence for Health Policy, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Aust N Z J Public Health 27:5-11. 2003
    ..To compare average levels of population health for Australia and other OECD countries in 2001...
  3. ncbi Global patterns of healthy life expectancy in the year 2002
    Colin D Mathers
    Evidence and Information for Policy, World Health Organization, Avenue Appia, Geneva, Switzerland
    BMC Public Health 4:66. 2004
    ..The World Health Organization reports on healthy life expectancy for 192 WHO Member States. This paper describes variation in average levels of population health across these countries and by sex for the year 2002...
  4. ncbi Global patterns of healthy life expectancy for older women
    Colin D Mathers
    Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    J Women Aging 14:99-117. 2002
    ..We discuss the implications of the findings for international health policy...
  5. ncbi Global burden of disease 2005: call for collaborators
    Christopher J L Murray
    Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98104, USA
    Lancet 370:109-10. 2007
  6. ncbi Can we reverse the HIV/AIDS pandemic with an expanded response?
    John Stover
    Futures Group International, Glastonbury, CT, USA
    Lancet 360:73-7. 2002
    ..Analyses suggest that if the successes achieved in some countries in prevention of transmission can be expanded to a global scale by 2005, about 29 million new infections could be prevented by 2010...
  7. ncbi Prospects for advancing tuberculosis control efforts through novel therapies
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e273. 2006
    ..As new candidates emerge from the global TB drug pipeline, the potential impacts of novel, shorter regimens on TB incidence and mortality have not yet been examined...
  8. ncbi [Priority setting for health interventions in Mexico's System of Social Protection in Health]
    Eduardo Gonzalez-Pier
    Unidad de Análisis Económico, Secretaria de Salud, Mexico, Paseo de la Reforma 450, PH, Col Juárez, 06600 Mexico, DF, Mexico
    Salud Publica Mex 49:S37-52. 2007
    ....
  9. ncbi Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
    Sun Young Kim
    Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
    Bull World Health Organ 85:833-42. 2007
    ..We sought to describe a method that explicitly considers both a health-care programmes cost-effectiveness and its affordability. For illustration, we apply the method to the programme to vaccinate infants against hepatitis B in the Gambia...
  10. ncbi Impact of HIV on novel therapies for tuberculosis control
    Maria S Sanchez
    Department of Environmental Science, Policy and Management, University of California, Berkeley, California 94720 3114, USA
    AIDS 22:963-72. 2008
    ..We investigated how tuberculosis is impacted by reducing treatment duration alone or combined with enhanced case detection and/or cure under different HIV prevalence levels...
  11. ncbi Cost-effectiveness of treating multidrug-resistant tuberculosis
    Stephen C Resch
    Department of Health Policy and Management, Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America
    PLoS Med 3:e241. 2006
    ..We projected the health benefits and cost-effectiveness of using drug susceptibility testing and second-line drugs in a lower-middle-income setting with high levels of MDR TB...
  12. ncbi Household and community socioeconomic and environmental determinants of child nutritional status in Cameroon
    Roland Pongou
    Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 6:98. 2006
    ..We further consider age-specific effects of household economic status on child nutrition...
  13. ncbi Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in Cameroon
    Roland Pongou
    Harvard School of Public Health, Boston, MA, USA
    Int J Epidemiol 35:648-56. 2006
    ..We examined the effects of economic crises and adjustment programmes during the 1990s in Cameroon on childhood malnutrition in population subgroups and evaluated the household and health system mediators of these effects...
  14. ncbi The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries
    John Stover
    Futures Group/Constella, Glastonbury, CT 06033, USA
    Science 311:1474-6. 2006
    ..Thus, greater spending on prevention now would not only prevent more than half the new infections that would occur from 2005 to 2015 but would actually produce a net financial saving as future costs for treatment and care are averted...
  15. ncbi Integrating HIV prevention and treatment: from slogans to impact
    Joshua A Salomon
    Harvard Center for Population and Development Studies, Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
    PLoS Med 2:e16. 2005
    ..In this paper, we quantify the opportunities and potential risks of large-scale treatment roll-out...
  16. ncbi Taking account of future technology in cost effectiveness analysis
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Harvard Center for Population and Development Studies, 9 Bow Street, Cambridge MA 02138, USA
    BMJ 329:733-6. 2004
  17. ncbi Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes
    Joshua A Salomon
    Department of Population and International Health, Center for Population and Development Studies, Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA
    BMJ 328:258. 2004
    ..To examine differences in expectations for health using anchoring vignettes, which describe fixed levels of health on dimensions such as mobility...
  18. ncbi Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population
    Joshua A Salomon
    Harvard Center for Population and Development Studies, Cambridge, Mass 02138, USA
    JAMA 290:228-37. 2003
    ..Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage...
  19. ncbi Evaluating the impact of antiretroviral therapy on HIV transmission
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 22:S149-59. 2008
    ....